The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review.
Hadrien GolaySimona Jurkovic MlakarVid MlakarTiago NavaMarc AnsariPublished in: International journal of molecular sciences (2019)
Hematopoietic stem cell transplantation (HSCT) remains the only curative treatment for several malignant and non-malignant diseases at the cost of serious treatment-related toxicities (TRTs). Recent research on extending the benefits of HSCT to more patients and indications has focused on limiting TRTs and improving immunological effects following proper mobilization and engraftment. Increasing numbers of studies report associations between HSCT outcomes and the expression or the manipulation of G protein-coupled receptors (GPCRs). This large family of cell surface receptors is involved in various human diseases. With ever-better knowledge of their crystal structures and signaling dynamics, GPCRs are already the targets for one third of the current therapeutic arsenal. The present paper assesses the current status of animal and human research on GPCRs in the context of selected HSCT outcomes via a systematized survey and analysis of the literature.
Keyphrases
- hematopoietic stem cell
- endothelial cells
- end stage renal disease
- cell surface
- current status
- acute myeloid leukemia
- systematic review
- prognostic factors
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- induced pluripotent stem cells
- metabolic syndrome
- type diabetes
- pluripotent stem cells
- skeletal muscle
- binding protein
- combination therapy
- glycemic control
- smoking cessation
- patient reported